S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

MRK Merck and Co Inc

96.81

0.50 (0.52%)

Last Updated: 09:08:28

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Merck (NYSE:MRK)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Merck Charts.

Merck (NYSE:MRK)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Merck Charts.

Merck and Co Inc News

Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment for Adult Patients With Unresectable Non-Epithelioid Malignant Pleural Mesothelioma (MPM)
Friday 15 November 2024 (3 days ago) • Business Wire

Merck to Participate in the Jefferies London Healthcare Conference
Thursday 14 November 2024 (4 days ago) • Business Wire

Merck Enters into Exclusive Global License for LM-299, An Investigational Anti-PD-1/VEGF Bispecific Antibody from LaNova Medicines Ltd.
Thursday 14 November 2024 (4 days ago) • Business Wire

KOSELUGO® (selumetinib) Showed Significant and Clinically Meaningful Improvement in Objective Response Rate Versus Placebo in Adults With Neurofibromatosis Type 1 who Have Symptomatic, Inoperable Plexiform Neurofibromas in Global Phase 3 KOMET Trial
Tuesday 12 November 2024 (6 days ago) • Business Wire

Merck to Present New Data From GARDASIL®9 Studies Reinforcing the Importance of Gender-Neutral HPV Vaccination in Adults Up to Age 45 at the International Papillomavirus Conference (IPVC) 2024
Tuesday 12 November 2024 (6 days ago) • Business Wire

L'Agence canadienne des médicaments recommande le remboursement de WINREVAIR® (sotatercept)
Friday 8 November 2024 (1 week ago) • PR Newswire (Canada)

Canada's Drug Agency Recommends WINREVAIR® (sotatercept) for Reimbursement
Friday 8 November 2024 (1 week ago) • PR Newswire (Canada)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Wednesday 6 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 6 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Merck to Participate in the UBS Global Healthcare Conference
Wednesday 6 November 2024 (2 weeks ago) • Business Wire

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Monday 4 November 2024 (2 weeks ago) • Edgar (US Regulatory)

U.S. Index Futures Decline; Oil Prices Rise on Strong Demand and OPEC+ Production Outlook
Thursday 31 October 2024 (3 weeks ago) • IH Market News

More Merck and Co Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions